Deep, qualified future-technology sequencing has revealed that subclonal mutations (i.e., those existing in only a fraction of tumor cells) can be detected for all driver genes and so are related to quick condition progression and inadequate consequence.11–13 This is especially pertinent for TP53Kami bekerjasama dengan beberapa pilihan supplier t